Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FFCD 2000-05: Treatment Strategy for Chemotherapy in Colorectal Cancer
NCT00126256Phase 3Completed
- Sponsor
- Gustave Roussy
- Start
- Feb 2002
- Primary completion
- Feb 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin in colorectal cancer (CRC), sponsored by Gustave Roussy. Started Feb 2002; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00126256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00126256.